Skip to main content
product bg
prod four

Betamethasone Dipropionate

Status

Commercial

Therapeutic Category

Anti-inflammatory

Pharmacopoeia

IP/ BP / USP/ EP

Cas no.

5593 – 20 – 4

DMF Status

CEP Planned

Product Remarks

ANVISA, KFDA

Application - injections, creams, foams, gels, lotions, ointments, syrups

Drug Description

Betamethasone Dipropionate is the 17,21-dipropionate ester of betamethasone, a synthetic glucocorticoid with metabolic, immunosuppressive and anti-inflammatory actions. Betamethasone dipropionate binds to specific intracellular glucocorticoid receptors and subsequently binds to DNA to modify gene expression. The synthesis of certain anti-inflammatory proteins is induced while the synthesis of certain inflammatory mediators is inhibited. As a result, there is an overall reduction in chronic inflammation and autoimmune reactions.

Contact Us

Connect with Avik Today